[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353993-105":59,"doc-detail-353993-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multidimensional-tumor-heterogeneity-and-its-role-in-therapeutic-resistance","Multidimensional tumor heterogeneity and its role in therapeutic resistance","","Multidimensional tumor heterogeneity drives therapeutic resistance across solid malignancies through genetic, epigenetic, phenotypic, spatial, temporal, and microenvironmental diversity. In mucosal barrier tumors, immune tolerance, chronic inflammation, and continuous antigen exposure further shape these heterogeneous states to enable immune escape and adaptive resistance. Myeloid cell plasticity links tumor-intrinsic heterogeneity with mucosal immune regulation by forming immunosuppressive niches and altering antigen presentation. Evidence from single-cell, spatial, imaging, and liquid biopsy approaches reveals convergent resistance mechanisms and guides emerging translational strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multidimensional-tumor-heterogeneity-and-its-role-in-therapeutic-resistance/353993/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multidimensional-tumor-heterogeneity-and-its-role-in-therapeutic-resistance/353993.png","ImageObject",300,407,{"name":92,"@type":93},"Aria Callaghan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What dimensions of tumor heterogeneity contribute to therapeutic resistance?","Question",{"text":112,"@type":113},"Therapeutic resistance is driven by heterogeneity across genetic, epigenetic, phenotypic, spatial, temporal, and microenvironmental dimensions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does mucosal tissue context influence immune escape and resistance?",{"text":117,"@type":113},"At mucosal barrier sites, immune tolerance, chronic inflammation, and continuous antigen exposure create permissive conditions that support immune escape and adaptive resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is myeloid cell plasticity important in shaping resistance?",{"text":121,"@type":113},"Myeloid plasticity enables functional diversification and contributes to spatial immunosuppressive niches, altered antigen processing and presentation, and therapy-induced immune remodeling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353993,1790143494,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Review  \nPUBLISHED 25 March 2026  \nDOI 10.3389/fimmu.2026.1794130  \nOPEN ACCESS  \nEDITED BY  \nFarha Naz,  \nUniversity of Virginia, United States  \nREVIEWED BY  \nAsrar Ahmad,  \nHoward University, United States John Manavalan,  \nUniversity of Virginia, United States  \n*CORRESPONDENCE  \nAnis Ahmad  \n[axa1458@med.miami.edu](axa1458@med.miami.edu)  \n†These authors have contributed equally to this work  \nRECEIVED 22 January 2026  \nREVISED 01 March 2026  \nACCEPTED 02 March 2026  \nPUBLISHED 25 March 2026  \nCITATION  \nMubin N, Alnukhali M, Ahmad N, Driscoll JJ and Ahmad A (2026)  \nMultidimensional tumor heterogeneity and its role in therapeutic resistance. Front. Immunol. 17:1794130 .  \ndoi: 10.3389/fimmu.2026.1794130  \nCOPYRIGHT  \n© 2026 Mubin, Alnukhali, Ahmad, Driscoll and Ahmad. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMultidimensional tumor heterogeneity and its role in therapeutic resistance  \nNida Mubin 1†, Mohammed Alnukhali 2,3†, Nayab Ahmad 2,3, James Joseph Driscoll 1,4 and Anis Ahmad 2,3*  \n1 Division of Hematology Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, United States, 2 Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, United States, 3 Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, United States, 4Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States  \nTumor heterogeneity is a fundamental driver of therapeutic resistance across solid malignancies, arising from genetic, epigenetic, phenotypic, spatial, temporal, and microenvironmental diversity. In tumors developing at mucosal barrier sites, these heterogeneous features are further shaped by the unique immunological context of mucosal tissues, where immune tolerance, chronic inﬂammation, and continuous antigen exposure create permissive environments for immune escape and adaptive resistance. Accumulating evidence indicates that myeloid cell plasticity, including functional diversiﬁcation of granulocytes, macrophages, monocytes, and dendritic cells, represents a critical interface between tumorintrinsic heterogeneity and mucosal immune regulation. These myeloid populations contribute to spatially organized immunosuppressive niches, altered antigen processing and presentation, and therapy-induced immune remodeling, collectively inﬂuencing responses to chemotherapy, targeted therapy, and immunotherapy. Advances in single-cell sequencing, spatial transcriptomics, multiplex imaging, and liquid biopsy technologies, coupled with artiﬁcial intelligence-enabled analytics, have enabled high-resolution mapping of heterogeneous tumor immune landscapes and revealed convergent resistance mechanisms driven by clonal selection, phenotypic plasticity, microenvironmental buffering, and myeloid-mediated immune suppression. In this review, we synthesize mechanistic and clinical evidence across major cancer types, including colorectal and lung cancers as archetypal mucosal tumors, along with broader examples from breast cancer, melanoma, and immunotherapy-treated malignancies. We highlight how heterogeneous cellular states and immune niches inﬂuence clinical outcomes. Finally, we discuss emerging translational strategies to overcome resistance, including rational combination regimens, epigenetic and metabolic targeting, adaptive therapy, myeloid reprogramming approaches, and real-time biomarker monitoring. These approaches aim to","cbCaihAWeZtTwzOc","https://ap.wps.com/l/cbCaihAWeZtTwzOc","pdf",4493208,22,"English","# 1 Introduction\n## 1.1 The central challenge: tumor heterogeneity as the root cause of therapeutic failure","[{\"question\":\"What dimensions of tumor heterogeneity contribute to therapeutic resistance?\",\"answer\":\"Therapeutic resistance is driven by heterogeneity across genetic, epigenetic, phenotypic, spatial, temporal, and microenvironmental dimensions.\"},{\"question\":\"How does mucosal tissue context influence immune escape and resistance?\",\"answer\":\"At mucosal barrier sites, immune tolerance, chronic inflammation, and continuous antigen exposure create permissive conditions that support immune escape and adaptive resistance.\"},{\"question\":\"Why is myeloid cell plasticity important in shaping resistance?\",\"answer\":\"Myeloid plasticity enables functional diversification and contributes to spatial immunosuppressive niches, altered antigen processing and presentation, and therapy-induced immune remodeling.\"}]","Multidimensional tumor heterogeneity and its role in therapeutic resistance | PDF",1790108376,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/271b934dc63057d385d5efbad263d717.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08b73e9cbbc41c4f7e41b8cb50ca5747.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18dc4129dd63264d642bd1a6012c73f6.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1de1cc57696029a91e15ae672aeb4717.webp",980,1385]